LAILIXIN
Dead / Abandoned — Abandoned — failure to respond (as of 20 Oct 2011)
What this means for you
This application is over — abandoned 14 Sept 2011. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76682427
- Mark type
- Stylized text
- Filed
- 01 Oct 2007
- Published for opposition
- 09 Sept 2008
- Abandoned
- 14 Sept 2011
- Attorney of record
- Jack Matalon
Goods and services
- Class 005 — Pharmaceuticals: Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets including Ace-inhibitors; Adrenergic agonists; Adrenergic blockers; Anabolics; Analgesics, narcotic and non-narcotic analgesics; Anesthetics; Antianorexics; Antacids; Anthelmintics; Antiacnes; Antiallergics; Antianginals; Antiarthritics and antirheumatics; Antiasthmatics; Antibacterials; Antibiotics; Anticoagulants; Anticonvulsants; Antidepressants; Antidiabetics; Antidiarrheals; Antidiuretics; Antiemetics; Antifungals; Antiglaucomas; Antihistaminics; Antihypertensives; Antihyperthyroids; Antihypotensives; Anti-inflammatories; Anti-itch creams, ointments and sprays; Antimalarials; Antimigraines; Antimuscarinics; Antineoplastics; Antioxidants; Antiparkinsonians; Antiprotozoals; Antipruritics; Antipsoriatics; Antipsychotics; Antiseborrheics; Antiseptics; Antispasmodics; Antisyphilitics; Antithrombotics; Antitussives; Antiulceratives; Antivirals; Anxiolyties; Astringents; Bacteriostats for medicinal, dental and veterinary use; Bath salts for medical purposes; Beta-blockers; Biocides; Biological and chemical reagents for medical or veterinary use; Bronchodilators; Burn-relief medications; Calcium channel blockers; Cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; Chemotherapeutics; Choleretics; Cholesterol reducers; Cholinergics; Cholinesterase inhibitors; Cleansing solutions for medical use; Clinical medical reagents; CNS stimulants; Contraceptives; Decongestants; Dermatologicals; Diagnostic preparations for medical purposes; Dietary and nutritional supplements; Diuretics; Dopamine receptor agonists; Enzyme cofactors; Estrogens; Expectorants; Food supplements; Gastric and pancreatic preparations; Germicides; Glucosidase inhibitors; Gonad-stimulating principles; Hematinics; Hematopoietics; Hemostatics; Hepatoprotectants; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Homeopathic supplements; Immunomodulators; Immunosuppressants; Laxatives; Medicinal herbal extracts; Mineral nutritional supplements; Mineralocorticoids; Mixed vitamin preparations; Mucolytics; Multi-vitamin preparations; Muscle relaxants; Mydriatics; Neutraceuticals for use as dietary supplements; Nootropics; Nutritional additives to foodstuffs for animals, for medical purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Plant extracts for medical, veterinary and pharmaceutical purposes; Processed food adapted for medical purposes; Progestogens; Prolactin inhibitors; Prostaglandins and prostaglandin analogs; dietary supplements; Respiratory stimulants; Reverse transcriptase inhibitors; Sedatives; Seratonin receptor agonists and antagonists; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; Vasodilators; Vasoprotectants; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
Owner
- ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY, Xinchang Zhejiang, CN
- ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY, Xinchang Zhejiang, CN
Prosecution history
- 21 Oct 2011 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 20 Oct 2011 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Mar 2011 — FINAL REFUSAL MAILED
- 13 Mar 2011 — SU - FINAL REFUSAL - WRITTEN
- 12 Aug 2010 — NON-FINAL ACTION MAILED
- 11 Aug 2010 — SU - NON-FINAL ACTION - WRITTEN
- 21 Jul 2010 — ASSIGNED TO EXAMINER
- 20 Jul 2010 — AMENDMENT FROM APPLICANT ENTERED
- 20 Jul 2010 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jul 2010 — PAPER RECEIVED
- 01 Jul 2010 — NON-FINAL ACTION MAILED
- 30 Jun 2010 — SU - NON-FINAL ACTION - WRITTEN
- 08 Jun 2010 — STATEMENT OF USE PROCESSING COMPLETE
- 19 May 2010 — USE AMENDMENT FILED
- 05 Jun 2010 — CASE ASSIGNED TO INTENT TO USE PARALEGAL